AXON

Axovant Sciences Ltd

(NO VEHICLES/GUIDED MISSILES)
MANUFACTURING

Prices are adjusted according to historical splits.

Axovant Sciences Ltd Stock Price

Vitals

Today's Low:
$144.8200
Today's High:
$149.6500
Open Price:
$146.6100
52W Low:
$82.49
52W High:
$209
Prev. Close:
$147.5900
Volume:
842603

Company Statistics

Market Cap.:
$10.434 billion
Book Value:
16.79
Revenue TTM:
$0.992 billion
Operating Margin TTM:
1.46%
Gross Profit TTM:
$0.541 billion
Gross Profit TTM:
$0.541 billion
Profit Margin:
14.2%
Return on Assets TTM:
0.52%
Return on Equity TTM:
12.3%

Company Profile

Axovant Sciences Ltd had its IPO on 2001-06-07 under the ticker symbol AXON.

The company operates in the MANUFACTURING sector and (NO VEHICLES/GUIDED MISSILES) industry. Axovant Sciences Ltd has a staff strength of 0 employees.

Stock update

Shares of Axovant Sciences Ltd opened at $146.61 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $144.82 - $149.65, and closed at $145.22.

This is a -1.61% slip from the previous day's closing price.

A total volume of 842,603 shares were traded at the close of the day’s session.

In the last one week, shares of Axovant Sciences Ltd have increased by +6%.

Axovant Sciences Ltd's Key Ratios

Axovant Sciences Ltd has a market cap of $10.434 billion, indicating a price to book ratio of 8.46 and a price to sales ratio of 10.52.

In the last 12-months Axovant Sciences Ltd’s revenue was $0.992 billion with a gross profit of $0.541 billion and an EBITDA of $0.037 billion. The EBITDA ratio measures Axovant Sciences Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Axovant Sciences Ltd’s operating margin was 1.46% while its return on assets stood at 0.52% with a return of equity of 12.3%.

In Q2, Axovant Sciences Ltd’s quarterly earnings growth was a negative -37.3% while revenue growth was a positive 30.5%.

Axovant Sciences Ltd’s PE and PEG Ratio

Forward PE
53.76
Trailing PE
71.61
PEG
2.86

Its diluted EPS in the last 12-months stands at $2.05 per share while it has a forward price to earnings multiple of 53.76 and a PEG multiple of 2.86. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Axovant Sciences Ltd’s profitability.

Axovant Sciences Ltd stock is trading at a EV to sales ratio of 9.82 and a EV to EBITDA ratio of 266.78. Its price to sales ratio in the trailing 12-months stood at 10.52.

Axovant Sciences Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Axovant Sciences Ltd ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Axovant Sciences Ltd ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Axovant Sciences Ltd’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Axovant Sciences Ltd's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Axovant Sciences Ltd paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$145.22
52-Week High
$209
52-Week Low
$82.49
Analyst Target Price
$146.73

Axovant Sciences Ltd stock is currently trading at $145.22 per share. It touched a 52-week high of $209 and a 52-week low of $209. Analysts tracking the stock have a 12-month average target price of $146.73.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Axovant Sciences Ltd

The stock symbol (also called stock or share ticker) of Axovant Sciences Ltd is AXON

The IPO of Axovant Sciences Ltd took place on 2001-06-07

Similar Industry Stocks ((NO VEHICLES/GUIDED MISSILES))

Last Price
Chg
Chg%
$28.58
-0.76
-2.59%
$11.08
-0.35
-3.06%
$55.62
-1.14
-2.01%
$69.34
-1.15
-1.63%
$1.17
0.01
+0.86%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Axon Enterprise, Inc. develops, manufactures, and sells conducted energy weapons (DEC) under the TASER brand name in the United States and internationally. The company is headquartered in Scottsdale, Arizona.

Address

17800 N. 85TH ST., SCOTTSDALE, AZ, US